Post by GSK

This week at #EHA2026 in Stockholm, we convened our Frontiers in Myeloma Roundtable, bringing together more than 55 patient advocates from 26 patient organisations across 25 countries. Our discussion focused on understanding the barriers impacting patients' ability to receive innovative multiple myeloma treatment close to home. We believe identifying and understanding these barriers is the first step in driving meaningful change and improving health equity. Learn more about multiple myeloma and access support resources: https://gsk.to/44g9Mo8